CVI Investments, Inc. 13D and 13G filings for Atossa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 4:09 pm Sale | 2024-12-31 | 13G | Atossa Therapeutics, Inc. ATOS | CVI Investments, Inc. | 5,662,500 4.300% | -2,100,000 (-27.05%) | Filing |
| 2022-02-14 3:16 pm Purchase | 2021-12-31 | 13G | Atossa Therapeutics, Inc. ATOS | CVI Investments, Inc. | 7,762,500 5.800% | 3,962,500 (+104.28%) | Filing |